1. 29-30 SEPTEMBER 2015 | THE MAJESTIC HOTEL, BARCELONA
POST EVENT REPORT
CELL & GENE
THERAPY EUROPE
127
Organisations
20
Countries
220+
Attendees
75
Speakers
73%
Director
and above
Silver sponsors Bronze sponsors
THANKS TO OUR SPONSORS
WWW.CGTEUROPE.COM
Gold Sponsor
"We've met a lot of new companies and made a
lot of new contacts. We are dealing with a global
industry now. We have found it hugely beneficial
and will definitely be coming again."
Robert Jones, General Manager, Fisher Bioservices

2. WWW.CGTEUROPE.COM
EXPERT SPEAKERS AT THE EVENT INCLUDED
MISSED CELL &
GENE THERAPY
EUROPE?
SEE ALL THE ACTION FROM
THE EVENT ONLINE HERE
“It was a very interesting event as all
participants, including speakers were
ready to exchange, even on the most
challenging subjects such as
reimbursement, GMP guidance.”
Bertrand Alexandre, Director, Marketing
Europe, Celyad
“Real forward-thinking combining
experts in the field from manufacturing,
regulatory and value vision” – “great
network with strong experience and
sharing risks & opportunities”
Jean-Philippe Combol, Chief Operating
Officer, GenSight Biologics
"I want to reinforce the comments you
have received that the Conference in
Barcelona was excellent in content,
interactions and atmosphere.”
Dr Carlos Plata, Chief Scientific Officer, Chief
Medical Officer & Head of R&D, Esteve
Dr Ruxandra
Draghia-Akli,
Director, Health
Dictorate, Research &
Innovation DG,
European Commission
Michael Covington,
Principal CMC
Regulatory Affairs Policy
& Strategy,
Juno
Dr Christian Meyer,
Chief Medical Officer,
uniQure
Dr Marcos Timon,
Head of Service,
AEMPS; Member,
Committee for
Advanced Therapies
(CAT)
Dr Kush Parmar,
Partner,
5AM Ventures
Edward Lanphier,
President & Chief
Executive Officer,
Sangamo BioSciences
Inc; Chairman,
Alliance of
Regenerative
Medicine (ARM)
Dr Leeza Osipenko,
Associate Director, NICE
Scientific Advice,
National Institute for
Health & Care
Excellence (NICE)
Dr Francois Meyer,
Advisor to the President,
International Affairs,
Haute Autorité de
Santé (HAS)
Dr Fatiha Sadallah,
Principal Scientific
Manager,
Innovative Medicines
Initiative
Prof. Chris Mason,
Chair of Regenerative
Medicine Bioprocessing,
University College
London
Ajan Reginald,
Chief Executive Officer,
Cell therapy Limited
Dr Maria Cristina Galli,
Co-chair of the ATMP
platform, EATRIS-
ERIC, the European
Infrastructure for
Translational
Medicine; Department
of Cell Biology and
Neurosciences,
Istituto Superiore di
Sanità
Dr Joern-Peter Halle,
Senior Vice President,
Global Head of External
Innovation,
Merck Serono
Dr Maria Pascual,
VP Regulatory Affairs &
Corporate Quality,
TiGenix
Dr Sven Kili,
Vice President & Head of
Gene Therapy
Development,
GlaxoSmithKline
Jan Thirkettle,
Vice President, Cell &
Gene Therapy Product
Development & Supply,
Platform Technology &
Sciences,
GlaxoSmithKline
Lennart Åkerblom,
Senior Expert, Medical
Products Agency
(MPA) Sweden &
Member, Committee
for Advanced
Therapies (CAT)
Dr Anton Simeonov,
Acting Deputy Scientific
Director, National
Centre for Advancing
Translational Sciences
(NCATS), NIH
Andrea Chiesi,
Director, R&D Portfolio
Management, Chiesi
Farmaceutici SpA; Co-
Founder & Chief
Executive Officer,
Holostem
Dr Ralf Sanzenbacher,
Deputy Head of Section,
Tissue-Engineering &
Cell Therapeutics, Paul-
Ehrlich-Institut,
Federal Institute for
Vaccines and
Biomedicines
Germany

3. I Head of Global Medical Affairs &
EU Clinical Development
I Vice President & Head of Gene
Therapy Development
I Senior Vice President, Clinical &
Regulatory
I Vice President, Manufacturing
I Vice President, Cell & Gene
Therapy Product Development
& Supply
I Senior Director, Scientific Affairs
& Analysis
I Global Head of Clinical
Development
I Chief Executive Officer
I Chief Medical Officer
I Chief Regulatory & Compliance
Officer
31% Vendors
7% Regulators
4% VCs
4% Academics
54%
Phama/
Biotech
SENIORITY LEVEL
ORGANISATION
TYPE
AUDIENCE PROFILE
ATTENDING COMPANIES INCLUDED
JOB TITLES INCLUDED
WWW.CGTEUROPE.COM
"The conference consistently proves to be a great forum for
networking with industry leaders in the development of
cellular and gene therapies as well as vendors for important
technologies and services.”
Michael Covington, Principal CMC Regulatory Affairs Policy &
Strategy, Juno Therapeutics, Inc
“Indeed, I found the meeting outstanding and have no
negative points (quite unusual for a regulator). Thank you for
your outstanding organizational support.”
Dr Ralf Sanzenbacher, Deputy Head of Section, Tissue-Engineering & Cell
Therapeutics, Paul-Ehrlich-Institut, Federal Institute for Vaccines and
Biomedicines Germany
73% Director level and above
17% Manager level
10% Academics / Scientists
REQUEST
THE FULL
ATTENDANCE
LIST HERE

4. REGISTRATION
MEETING VILLAGE
21
25 31
14
15
16
17
18
19
23
24
1
2
3
4
5
6
7
8 9
10 11
12 13
28
27
26
30
20
21 - 22 SEPTEMBER 2016 | THE MARITIM HOTEL, BERLIN
IMMUNOTHERAPY
EUROPE
CELL & GENE
THERAPY EUROPE
Following the sell-out success of
Cell & Gene Therapy Europe 2015,
Phacilitate will be launching
Immunotherapy Europe alongside
the 2016 edition of Cell & Gene
Therapy Europe.
Join us and hundreds of cell, gene
and immunotherapy executives in
Berlin. Contact Michael
michael@phacilitate.co.uk or
on +44 (0)207 384 7951 to find
out how.
SPONSORS ALREADY CONFIRMED
JOIN US IN WASHINGTON 25 - 27 JANUARY 2016!
Don’t miss the next edition of Cell & Gene Therapy World when it returns to
Washington DC this January. With even more content streams, exciting new
features and an even larger audience to network and collaborate with, you can’t
afford to miss the world’s premier cell and gene therapy event.
Find out more at www.bioleaders-forum.com now
CONTACT US
SPONSORSHIP ENQUIRIES:
Michael Adeniya
Business Development
Director
E: michael@phacilitate.co.uk
T: +44 (0)207 384 7951
DELEGATE ENQUIRIES:
Kim Evans
Senior Programme Manager
E: kim@phacilitate.co.uk
T: +44 (0)207 384 7993
CONTENT & OVERALL EVENT
ENQUIRIES:
James McGough
Portfolio Director
E: james@phacilitate.co.uk
T: +44 (0)207 384 7971
MEDIA & MARKETING
ENQUIRIES:
Carina Hunter
Marketing Manager
E: carina@phacilitate.co.uk
T: +44 (0)207 384 7897
NEXT YEAR'S DATES CONFIRMED! SIGN UP NOW FOR BERLIN 2016!